In addition to PCDH17, our earlier studies have established the prognostic significances of some other Wnt antagonists in AML, such as SOX17, NKD2, and SFRP genes [31–33], highlighting the importance of deregulated Wnt signaling in leukemogenesis. The gene discussed is NKD2; the disease is acute myeloid leukemia.